EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility study: Characterizing acute lesion dimensions in patients with and without devices using noncontrast (native T1-weighted) magnetic resonance imaging after ventricular tachycardia/premature ventricular complex radiofrequency ablation

Terenz Escartin, Maria Terricabras, Calder Sheagren, Philippa Krahn, Idan Roifman, Graham Wright, Christopher C Cheung

Heart Rhythm · 2025

DOI: 10.1016/j.hrthm.2025.06.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2025. Verfasst von Terenz Escartin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute, Toronto, Ontario, Canada. Electroni…. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation, Magnetic Resonance Imaging, Cine, Ventricular Premature Complexes. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Late gadolinium enhancement magnetic resonance imaging (MRI) has been shown to reliably locate radiofrequency ablation (RFA) lesions with microvascular obstruction (MVO) as a broadly accepted signature. However, MVO volume depends on the time elapsed after gadolinium contrast injection. Native T1-weighted (T1w) MRI has recently been shown to accurately characterize RFA lesions in preclinical models. OBJECTIVE: This study aimed to demonstrate the feasibility of wideband native T1w MRI in characterizing lesion dimensions in patients within 7 days of ventricular tachycardia RFA. METHODS: Postablation wideband native T1w and 3-dimensional late gadolinium enhancement MRI was performed within 7 days of RFA. RFA lesion surface area (mm2), volume (mm3), and native T1w maximum lesion depth were calculated. Average catheter contact force (g), ablation duration (seconds), and impedance drop (Ω) were calculated. Patients with and without implantable cardioverter-defibrillators were included. RESULTS: Ten patients (median age = 64.5 years, 60% ischemic) underwent ventricular tachycardia RFA (80% endocardial, 20% epicardial RFA) and postablation cardiac MRI within 7 days of RFA (median = 4.5 days). There was a significantly greater mean MVO surface area and volume than mean native T1w lesion surface area and volume (P = .0108, P = .0376, P < .05), respectively. There were strong positive correlations between average surface area and average volume measured by MVO and native T1w (r = 0.71, P = .0237, r = 0.70, P = .0265, P < .05), respectively. Average maximum native T1w lesion depth correlated with average ablation duration and average impedance drop (r = 0.73, P = .02, r = 0.68, P = .04, P < .05), respectively. CONCLUSION: Native T1w MRI can effectively characterize lesion dimensions in patients with and without implantable cardioverter-defibrillators within 7 days after ablation. This emerging biomarker may facilitate early prediction of RFA efficacy and ablation success particularly in patients demonstrating contraindications to gadolinium contrast agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCatheter AblationMagnetic Resonance Imaging, CineVentricular Premature ComplexesDefibrillators, ImplantableMagnetic Resonance ImagingHumansFeasibility StudiesMaleFemaleMiddle AgedAgedContrast Media

Stichwörter der Autor:innen

Ablation lesion characterizationLate gadolinium enhancement MRINative T(1)-weighted MRIRadiofrequency ablationVentricular tachycardia

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute, Toronto, Ontario, Canada. Electronic address: terenz.escartin@mail.utoronto.ca.
  • Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Research Institute, Toronto, Ontario, Canada.

Förderung

  • CIHR

Zitieren

APA

Escartin, T., Terricabras, M., Sheagren, C., Krahn, P., Roifman, I., Wright, G., & Cheung, C. C. (2025). Feasibility study: Characterizing acute lesion dimensions in patients with and without devices using noncontrast (native T1-weighted) magnetic resonance imaging after ventricular tachycardia/premature ventricular complex radiofrequency ablation. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.06.024

Vancouver

Escartin T, Terricabras M, Sheagren C, Krahn P, Roifman I, Wright G, et al. Feasibility study: Characterizing acute lesion dimensions in patients with and without devices using noncontrast (native T1-weighted) magnetic resonance imaging after ventricular tachycardia/premature ventricular complex radiofrequency ablation. Heart Rhythm. 2025. doi:10.1016/j.hrthm.2025.06.024

BibTeX
@article{Escartin2025,
  author = {Escartin, Terenz and Terricabras, Maria and Sheagren, Calder and Krahn, Philippa and Roifman, Idan and Wright, Graham and Cheung, Christopher C},
  title = {Feasibility study: Characterizing acute lesion dimensions in patients with and without devices using noncontrast (native T1-weighted) magnetic resonance imaging after ventricular tachycardia/premature ventricular complex radiofrequency ablation},
  journal = {Heart Rhythm},
  year = {2025},
  doi = {10.1016/j.hrthm.2025.06.024}
}
Kostenlos starten →